Skip to content

Neuronetics STIM Inventories

Inventories at other companies

CVRx, Inc. logo
CVRx, Inc.CVRX
$12.4M+6.3%
Stereotaxis logo
StereotaxisSTXS
$10.5M+7.0%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$16.69M+22.9%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$8.57M+7,912%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$177.82M+1.9%
Myriad Genetics logo
Myriad GeneticsMYGN
$27.9M-1.4%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's inventories?
Neuronetics (STIM) reported inventories of $4.72M in Q1 2026.
How has Neuronetics's inventories changed year-over-year?
Neuronetics's inventories increased by 15.9% year-over-year, from $4.07M to $4.72M.
What is the long-term trend for Neuronetics's inventories?
Over 5 years (2020 to 2025), Neuronetics's inventories has grown at a 3.1% compound annual growth rate (CAGR), from $3.72M to $4.33M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.